DGAP-News: MPH Mittelständische Pharma Holding AG: 1st Quarter 2013: +31.4% in Sales; +34.3% in EBIT
(firmenpresse) - DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s):
Quarter Results/Development of Sales
MPH Mittelständische Pharma Holding AG: 1st Quarter 2013: +31.4% in
Sales; +34.3% in EBIT
23.05.2013 / 08:15
---------------------------------------------------------------------
MPH Mittelständische Pharma Holding AG:
1st Quarter 2013: +31.4% in Sales; +34.3% in EBIT
For the first three months of the current year, the Group is reporting
sales of EUR 53.42 million, with thus representing an increase of 31.4 %
compared to the same period of the previous year (prior-year period: EUR
40.66 million). The consolidated profit before interests and taxes (EBIT)
for January through March 2013, at EUR 4.15 million, was 34.3 % above the
prior-year level (EUR 3.09 million). An EBIT margin of 7.8% was achieved.
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has
strategically concentrated its activities on growth segments Pharma and
Healthcare. On the basis of patent-free and patent-protected active
substances, production and consultancy services for therapies of chronic
diseases, the Group makes a precious contribution to keeping health
affordable.
MPH Mittelständische Pharma Holding AG is listed in the Entry Standard
(Open Market) of the Frankfurt stock exchange.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 41.167.155
Listed shares: Preference shares
Number of preference shares in circulation: 19.025.000
ISIN: DE000A0NF697
WKN: A0NF69
Stock symbol: 93MV
Contact:
Linda Reichelt
MPH Mittelständische Pharma Holding AG
Fasanenstraße 77
D-10623 Berlin
Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308670
E-Mail: ir(at)mph-ag.de Web: www.mph-ag.de
End of Corporate News
---------------------------------------------------------------------
23.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MPH Mittelständische Pharma Holding AG
Fasanenstraße 77
10623 Berlin
Germany
Phone: 030 / 897 308 660
Fax: 030 / 897 308 670
E-mail: info(at)mph-ag.de
Internet: www.mph-ag.de
ISIN: DE000A0NF697
WKN: A0NF69
Listed: Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in
Open Market (Entry Standard)
End of News DGAP News-Service
---------------------------------------------------------------------
212404 23.05.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.05.2013 - 08:15 Uhr
Sprache: Deutsch
News-ID 262779
Anzahl Zeichen: 4853
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 201 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MPH Mittelständische Pharma Holding AG: 1st Quarter 2013: +31.4% in Sales; +34.3% in EBIT"
steht unter der journalistisch-redaktionellen Verantwortung von
MPH Mittelständische Pharma Holding AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
